- Home
- CLGN vs DLXY Comparison
CLGN vs DLXY Comparison
Compare CLGN & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLGN | DLXY |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 15.5M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | CLGN | DLXY |
|---|---|---|
| Price | $0.71 | $0.87 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 114.3K | 60.1K |
| Earning Date | 03-25-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1077.13 |
| EPS | N/A | ★ 0.08 |
| Revenue | $2,475,000.00 | ★ $273,155,000.00 |
| Revenue This Year | $1,596.12 | N/A |
| Revenue Next Year | $85.83 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | ★ 280.77 | N/A |
| 52 Week Low | $0.59 | $0.61 |
| 52 Week High | $4.98 | $7.16 |
Technical Indicators
Market Signals| Indicator | CLGN | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 28.16 | 46.35 |
| Support Level | $0.66 | $0.84 |
| Resistance Level | $0.74 | $0.95 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 8.57 | 9.95 |
Price Performance
Historical ComparisonAbout CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About DLXY Delixy Holdings Limited Ordinary Shares
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.